Alpha 4 beta 7 integrin inhibitor (C4X Discovery)

N/A

Report date: 2025/07/16 15:39:46
NME

Base Information

Drug NameAlpha 4 beta 7 integrin inhibitor (C4X Discovery)
Drug Alias Nameα4β7 inhibitor (C4X Discovery)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-4/beta-7 inhibitors
TargetsIntegrin alpha-4/beta-7
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesC4X Discovery Holdings plc
China Registration ClassN/A

Develop Information

Active CompaniesC4X Discovery Holdings plc
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A